Skip to content
Search

Latest Stories

Patch up differences and start afresh, AIMp chief urges community pharmacy, NHS

The Association of Independent Multiple Pharmacies (AIMp) has called for a "new understanding" between the NHS and England's community pharmacies to avert further pharmacy closures and rejuvenate the whole sector.

Leyla Hannbeck, AIMp chief executive, said the pharmacies see themselves as “under-valued and unloved” despite proving their worth during the pandemic.


“Yet sadly, pharmacies are closing. They don’t feel respected - not by the public, but by some health authorities and NHS executives,” she said in a statement.

Speaking to The Mail on Sunday, she added that a “snobbish attitude” among some in the NHS saw pharmacists “perceived incorrectly as businesspeople first and healthcare providers second”, while the regard in which they were held was “lower than clinical practitioners and GPs.”

In the statement, Hannbeck also urged pharmacies to take a “long and hard look at themselves, their offering and appearance,” adding that the sector has not helped itself in the past.

“This should be done in conjunction with a new deal, a new relationship with community pharmacy. We need to use the pandemic and the review of healthcare that is now underway, as an opportunity to repair relations, to place community pharmacies at the forefront of our health system.”

Noting that pharmacies could be doing more vaccinating now against Covid-19, she suggested the government need to immediately address the issue of £370 million extra costs incurred in combating the pandemic.

Longer-term, there must be “greater clarity and consistency in the referral of patients from NHS111 and GPs to community pharmacies,” he said.

“We’re able to participate more fully in the roll-out of new medicines and therapies. Rather than being on the periphery of discussions concerning the various medicine distribution models we should be fully consulted, exploiting our know-how.”

She added that a “new understanding” is required  and that must be a redrawn contract, “a new financial framework – one that we can work with, without having to complain and fight for, and one, equally, that all the NHS is happy to apply.”

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less